Congratulation to DBPR807 team on receiving the 18th National Innovation Award in the Academic Research Category
“Development of CXCR4-Targeting Antagonists for Ac…
“Development of CXCR4-Targeting Antagonists for Ac…
“Discovery and development of novel anti-diabetic …
Dr. Lun Kelvin Tsou, Associate Investigator of IBP…
Dr. Hsing-Pang Hsieh, Investigator of IBPR, was aw…
Dr. Lun Kelvin Tsou, Associate Investigator of IBP…
Leading by Dr. Hsing-Pang Hsieh, the DBPR114 team …
To strengthen the integration of technical researc…
The “Technology Transfer Award” is one…
Phase 1 clinical trial of the novel anti-diabetic …